which glp is tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide 10mg — Dual Receptor
Description
Starting in July 2026, eligible Medicare beneficiaries will gain access to certain weight-loss medications for $50 a month through a temporary initiative called the Medicare GLP-1 Bridge program
These changes contribute to improved endothelial function, reduced arterial stiffness, and better left ventricular compliance, especially relevant in HFpEF [30]
At 15mg per week, approximately 6.5 weeks
What Comes After Tirzepatide
No surprise charges
